Pediatric drug hypersensitivity

Which diagnostic tests?

Francesca Saretta, Francesca Mori, Fabio Cardinale, Lucia Liotti, Fabrizio Franceschini, Giuseppe Crisafulli, Silvia Caimmi, Paolo Bottau, Roberto Bernardini, Carlo Caffarelli

Research output: Contribution to journalReview article

Abstract

Along with the anamnesis and clinical evaluation, diagnostic tests are one of the mainstream key points in the evaluation and management of drug hypersensitivity reactions (DHR). A wide knowledge gap, both in diagnosis and management of pediatric DHR, must be filled. Only a few published studies evaluated sensitivity and specificity of skin and in vitro tests in children. However, selected case series show that diagnostic work-up for adults could be useful, with some limitations, in pediatric age. Indeed, despite improvement in in vivo and in vitro diagnosis, drug provocation test remains the gold standard in pediatric age, too. Unmet needs in children include multi-centric studies on incidence of DHR, utility and feasibility of in vivo and in vitro diagnostic tests and specifically dedicated guidelines for the diagnosis and management of DHR in children. (www.actabiomedica.it).

Original languageEnglish
Pages (from-to)94-107
Number of pages14
JournalActa Biomedica
Volume90
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Drug Hypersensitivity
Routine Diagnostic Tests
Pediatrics
Cohort Studies
Guidelines
Sensitivity and Specificity
Skin
Pharmaceutical Preparations
In Vitro Techniques

Keywords

  • Basophil activation test
  • Children
  • Drug hypersensitivity reactions
  • Druprovocation test
  • Skin test
  • Specific IgE

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Saretta, F., Mori, F., Cardinale, F., Liotti, L., Franceschini, F., Crisafulli, G., ... Caffarelli, C. (2019). Pediatric drug hypersensitivity: Which diagnostic tests? Acta Biomedica, 90, 94-107. https://doi.org/10.23750/abm.v90i3-S.8171

Pediatric drug hypersensitivity : Which diagnostic tests? / Saretta, Francesca; Mori, Francesca; Cardinale, Fabio; Liotti, Lucia; Franceschini, Fabrizio; Crisafulli, Giuseppe; Caimmi, Silvia; Bottau, Paolo; Bernardini, Roberto; Caffarelli, Carlo.

In: Acta Biomedica, Vol. 90, 01.01.2019, p. 94-107.

Research output: Contribution to journalReview article

Saretta, F, Mori, F, Cardinale, F, Liotti, L, Franceschini, F, Crisafulli, G, Caimmi, S, Bottau, P, Bernardini, R & Caffarelli, C 2019, 'Pediatric drug hypersensitivity: Which diagnostic tests?', Acta Biomedica, vol. 90, pp. 94-107. https://doi.org/10.23750/abm.v90i3-S.8171
Saretta F, Mori F, Cardinale F, Liotti L, Franceschini F, Crisafulli G et al. Pediatric drug hypersensitivity: Which diagnostic tests? Acta Biomedica. 2019 Jan 1;90:94-107. https://doi.org/10.23750/abm.v90i3-S.8171
Saretta, Francesca ; Mori, Francesca ; Cardinale, Fabio ; Liotti, Lucia ; Franceschini, Fabrizio ; Crisafulli, Giuseppe ; Caimmi, Silvia ; Bottau, Paolo ; Bernardini, Roberto ; Caffarelli, Carlo. / Pediatric drug hypersensitivity : Which diagnostic tests?. In: Acta Biomedica. 2019 ; Vol. 90. pp. 94-107.
@article{ca5682e5fce04f179da9474259f07417,
title = "Pediatric drug hypersensitivity: Which diagnostic tests?",
abstract = "Along with the anamnesis and clinical evaluation, diagnostic tests are one of the mainstream key points in the evaluation and management of drug hypersensitivity reactions (DHR). A wide knowledge gap, both in diagnosis and management of pediatric DHR, must be filled. Only a few published studies evaluated sensitivity and specificity of skin and in vitro tests in children. However, selected case series show that diagnostic work-up for adults could be useful, with some limitations, in pediatric age. Indeed, despite improvement in in vivo and in vitro diagnosis, drug provocation test remains the gold standard in pediatric age, too. Unmet needs in children include multi-centric studies on incidence of DHR, utility and feasibility of in vivo and in vitro diagnostic tests and specifically dedicated guidelines for the diagnosis and management of DHR in children. (www.actabiomedica.it).",
keywords = "Basophil activation test, Children, Drug hypersensitivity reactions, Druprovocation test, Skin test, Specific IgE",
author = "Francesca Saretta and Francesca Mori and Fabio Cardinale and Lucia Liotti and Fabrizio Franceschini and Giuseppe Crisafulli and Silvia Caimmi and Paolo Bottau and Roberto Bernardini and Carlo Caffarelli",
year = "2019",
month = "1",
day = "1",
doi = "10.23750/abm.v90i3-S.8171",
language = "English",
volume = "90",
pages = "94--107",
journal = "Acta Biomedica de l'Ateneo Parmense",
issn = "0392-4203",
publisher = "L'Ateneo Parmense",

}

TY - JOUR

T1 - Pediatric drug hypersensitivity

T2 - Which diagnostic tests?

AU - Saretta, Francesca

AU - Mori, Francesca

AU - Cardinale, Fabio

AU - Liotti, Lucia

AU - Franceschini, Fabrizio

AU - Crisafulli, Giuseppe

AU - Caimmi, Silvia

AU - Bottau, Paolo

AU - Bernardini, Roberto

AU - Caffarelli, Carlo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Along with the anamnesis and clinical evaluation, diagnostic tests are one of the mainstream key points in the evaluation and management of drug hypersensitivity reactions (DHR). A wide knowledge gap, both in diagnosis and management of pediatric DHR, must be filled. Only a few published studies evaluated sensitivity and specificity of skin and in vitro tests in children. However, selected case series show that diagnostic work-up for adults could be useful, with some limitations, in pediatric age. Indeed, despite improvement in in vivo and in vitro diagnosis, drug provocation test remains the gold standard in pediatric age, too. Unmet needs in children include multi-centric studies on incidence of DHR, utility and feasibility of in vivo and in vitro diagnostic tests and specifically dedicated guidelines for the diagnosis and management of DHR in children. (www.actabiomedica.it).

AB - Along with the anamnesis and clinical evaluation, diagnostic tests are one of the mainstream key points in the evaluation and management of drug hypersensitivity reactions (DHR). A wide knowledge gap, both in diagnosis and management of pediatric DHR, must be filled. Only a few published studies evaluated sensitivity and specificity of skin and in vitro tests in children. However, selected case series show that diagnostic work-up for adults could be useful, with some limitations, in pediatric age. Indeed, despite improvement in in vivo and in vitro diagnosis, drug provocation test remains the gold standard in pediatric age, too. Unmet needs in children include multi-centric studies on incidence of DHR, utility and feasibility of in vivo and in vitro diagnostic tests and specifically dedicated guidelines for the diagnosis and management of DHR in children. (www.actabiomedica.it).

KW - Basophil activation test

KW - Children

KW - Drug hypersensitivity reactions

KW - Druprovocation test

KW - Skin test

KW - Specific IgE

UR - http://www.scopus.com/inward/record.url?scp=85062392173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062392173&partnerID=8YFLogxK

U2 - 10.23750/abm.v90i3-S.8171

DO - 10.23750/abm.v90i3-S.8171

M3 - Review article

VL - 90

SP - 94

EP - 107

JO - Acta Biomedica de l'Ateneo Parmense

JF - Acta Biomedica de l'Ateneo Parmense

SN - 0392-4203

ER -